Načítá se...
Retargeting T Cells for HER2-Positive Tumor Killing by a Bispecific Fv-Fc Antibody
To exploit the biological and pharmacological properties of immunoglobulin constant domain Fc fragment and increase the killing efficacy of T cells, a single chain variable fragment specific to CD3 was fused with Fcab (Fc antigen binding), a mutant Fc fragment with specificity against Human epiderma...
Uloženo v:
| Hlavní autoři: | , , , , , , , , , |
|---|---|
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Public Library of Science
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3781095/ https://ncbi.nlm.nih.gov/pubmed/24086580 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0075589 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|